Hudson Bay Capital Management’s Sangamo Therapeutics SGMO Stock Holding History

Hudson Bay Capital Management’s Portfolio SGMO Stock Details SGMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-42,370	Closed	-$27.8K	–	1158
2025 Q1	$27.8K	Buy	+42,370	New	+$27.8K	﹤0.01%	811
2024 Q3	–	Sell	-135,000	Closed	-$48.4K	–	810
2024 Q2	$48.4K	Sell	135,000 -1,238,500	-90%	-$444K	﹤0.01%	555
2024 Q1	$921K	Sell	1,373,500 -1,126,500	-45%	-$755K	0.01%	459
2023 Q4	$1.36M	Buy	2,500,000 +1,201,500	+93%	+$653K	0.01%	422
2023 Q3	$779K	Sell	1,298,500 -26,500	-2%	-$15.9K	0.01%	501
2023 Q2	$1.72M	Buy	1,325,000 +125,000	+10%	+$163K	0.01%	461
2023 Q1	$2.11M	Buy	1,200,000 +42,400	+4%	+$74.6K	0.02%	471
2022 Q4	$3.63M	Buy	1,157,600 +257,600	+29%	+$809K	0.04%	424
2022 Q3	$4.41M	Hold	900,000	–	–	0.04%	435
2022 Q2	$3.73M	Buy	900,000 +120,000	+15%	+$497K	0.03%	529
2022 Q1	$4.53M	Buy	780,000 +180,000	+30%	+$1.05M	0.06%	396
2021 Q4	$4.5M	Buy	600,000 +125,000	+26%	+$938K	0.05%	365
2021 Q3	$4.28M	Buy	475,000 +25,000	+6%	+$225K	0.06%	390
2021 Q2	$5.39M	Buy	450,000 +115,000	+34%	+$1.38M	0.07%	301
2021 Q1	$4.2M	Sell	335,000 -25,000	-7%	-$313K	0.05%	340
2020 Q4	$5.62M	Sell	360,000 -120,000	-25%	-$1.87M	0.06%	199
2020 Q3	$4.54M	Sell	480,000 -40,000	-8%	-$378K	0.07%	236
2020 Q2	$4.66M	Sell	520,000 -155,000	-23%	-$1.39M	0.08%	199
2020 Q1	$4.3M	Buy	675,000 +415,000	+160%	+$2.64M	0.11%	167
2019 Q4	$2.18M	Buy	260,000 +80,000	+44%	+$670K	0.05%	253
2019 Q3	$1.63M	Sell	180,000 -20,000	-10%	-$181K	0.05%	259
2019 Q2	$2.15M	Buy	200,000 +170,000	+567%	+$1.83M	0.05%	237
2019 Q1	$286K	Hold	30,000	–	–	﹤0.01%	386
2018 Q4	$344K	Buy	30,000 +10,000	+50%	+$115K	﹤0.01%	403
2018 Q3	$339K	Sell	20,000 -10,000	-33%	-$170K	﹤0.01%	403
2018 Q2	$426K	Buy	+30,000	New	+$426K	0.01%	415
2017 Q3	–	Sell	-45,000	Closed	-$396K	–	399
2017 Q2	$396K	Buy	+45,000	New	+$396K	0.01%	297